Edwards Lifesciences

About Edwards Lifesciences

Edwards Lifesciences is a global leader in patient-focused innovations for structural heart disease and critical care monitoring. Founded in 1958, the company has dedicated itself to advancing the treatment of cardiovascular diseases through innovative technologies and solutions.

With a strong commitment to research and development, Edwards Lifesciences focuses on creating products that improve patient outcomes and enhance the quality of life. The company’s core activities include the design and manufacture of heart valves, hemodynamic monitoring systems, and surgical instruments.

Edwards Lifesciences operates in over 100 countries, providing healthcare professionals with the tools they need to deliver optimal care. The company’s flagship products, such as the transcatheter aortic valve replacement (TAVR) system, have revolutionised the treatment of aortic stenosis, offering less invasive options for patients.

In addition to its innovative products, Edwards Lifesciences is committed to education and training for healthcare providers, ensuring they are equipped with the latest knowledge and skills to use their technologies effectively.

The company’s vision is to transform patient care by delivering innovative solutions that address unmet medical needs. Edwards Lifesciences strives to lead the way in the field of cardiovascular medicine, driven by a passion for improving lives.

Through its dedication to quality, innovation, and patient-centric care, Edwards Lifesciences continues to set new standards in the healthcare industry.